Today’s AI Top Pick: ALNY

7/31/2026 · Recently Alerted GARP screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Recently Alerted GARPALNYBUY NOW9.0 / 107/31/2026

Alnylam is the cleanest 'coiled spring' setup on the board. The stock is deeply washed out — RSI 23.52, YTD -48.33%, weekly drawdown -33.96%, position_in_21bar_range at 0-7% on every timeframe — but the forecast tape and the fundamentals are pointing violently the other way. Kronos short/mid/long forecasts are +48.7/+49.7/+48.9% on 1h, +46.4/+56.5/+78.8% on 4h, and +54.1/+82.5/+70.1% on 1d, with bullish_prob 1.0 and near_term_bullish 1.0. You almost never get forecast magnitudes like that combined with fundamentals this strong. The fundamentals are elite even within a GARP screen: PEG 0.26 (2nd cheapest here), fwdPe 20.58, ROE 96.94, sales growth 82.57% Y/Y, gross margin 80.83%, and analyst target upside +95.5% with recom 1.67. Crucially, the news is a real catalyst rather than a landmine: the July 30 Q2 print showed Amvuttra surpassing the $1B milestone — that is exactly the kind of commercial inflection that stops a multi-quarter bleed and turns forced sellers into forced buyers. The fact that the stock hasn't ripped yet is why this is a today trade, not a next-week trade. Why TODAY over waiting: position_in_21bar_range is essentially zero across 1h/4h/1d — there is no chase here, you're buying at the low of the range on a fresh earnings beat. The only 'weak' signal is the 1wk forecast (+3.4/+11.4/+10.0), which is normal when a stock has just capitulated; the weekly needs another bar or two to turn, but the daily and intraday tape are already telling you where it's going. Waiting for the weekly to confirm means paying up 20-30%. I passed on FICO despite the screen match (worst single-day drop in 6 years on downside guidance July 30 — thesis broken), on PFSI (Piper Sandler downgrade, price falling), and on ITRG (Zacks Strong Sell July 30) — good screen scores, bad news undercuts. PODD and PDD are the strongest alternatives with cleaner multi-TF agreement, but neither has ALNY's magnitude of oversold snapback + fresh positive earnings catalyst.

Entry zone

$204-$210 (current $206.99, buy on any intraday dip toward $205; a fill in the $200-$204 zone is a gift)

Stop loss

$184 (below the 21-bar low; ~11% risk — necessary given the volatility, but justified by forecast magnitude of 50%+)

First target

$245-$255 (roughly the +20% short-horizon forecast; aligns with pre-drop consolidation)

Longer target

$310-$340 (the +50-70% mid/long-horizon forecast band; also lines up with the 95.5% analyst target upside)

Risks

1wk forecasts are only +3.4/+11.4/+10.0 — the weekly trend has NOT turned yet, so this is a countertrend bounce trade until the weekly closes green
Debt/Equity 2.76 is the highest in the top tier — any commercial disappointment after the Amvuttra ramp gets punished harder
Down 48% YTD and 39.5% Y/Y — sentiment is fragile; a broad biotech risk-off day could re-test the lows before the bounce
Profit margin 13.46% is thin for a specialty biotech at this valuation (fwdPe 20.58); the growth story has to keep delivering
Institutional ownership 98.91% means concentrated holders — if a large fund keeps unwinding, the bid can vanish

Honorable mentions

PODDCleanest multi-TF alignment on the entire board: 1h/4h/1d/1wk forecasts ALL positive (+8.89 to +64.16), near_term_bullish 1.0, pos_in_range a healthy 22-70% (not chasing), PEG 0.77, ROE 23, sales +31.93%. Q2 earnings upcoming is the only reason it's #2 vs #1 — event risk before the print.

PDDCheapest quality name here — fwdPe 7.06, PEG 0.63, profit margin 21.86%, ROE 25.52, zero debt. All four TFs green (+15.82/+23.78/+23.80 on daily), bullish_prob 1.0. Slight chase risk with pos_in_range 88-90% on 4h/1d, so ideal on a small pullback to $84-85.

Full ranking (31)

#	Symbol	Verdict	Score	Read
1	ALNY	BUY NOW	9.0	Deep oversold (RSI 23, pos_in_range ~0) with +50-80% forecasts and a fresh Amvuttra >$1B earnings catalyst — coiled spring.
2	PODD	BUY NOW	8.6	Best multi-TF alignment on the board with all four horizons green and clean fundamentals; Q2 print is the swing factor.
3	PDD	BUY NOW	8.2	Cheapest quality name (fwdPe 7.06, PEG 0.63) with all TFs positive; only knock is elevated pos_in_range on 4h/1d.
4	FUTU	BUY PULLBACK	7.4	Explosive 1h/4h/1d forecasts (+44/+50/+60) but weekly rolling over and pos_in_range 90-98% — wait for a dip to $95.
5	BILI	BUY PULLBACK	7.2	Strong short/mid TF forecasts (+15 to +39) with positive 2Q26 preview, but pos_in_range 88-96% on 4h/1d.
6	HSAI	BUY PULLBACK	6.9	+25-45% short/mid forecasts and positive robotics narrative, but weekly forecast is deeply negative (-9/-21/-26).
7	ORCL	BUY PULLBACK	6.7	Strong daily forecast (+37.57 mid) and 96.7% analyst upside, but pos_in_range 100% on 4h — don't chase.
8	GRAB	BUY PULLBACK	6.4	Solid 4h/1d forecasts (+25/+31 mid) and cheap PEG 0.40, but insider selling headline is a mild drag.
9	NRDS	BUY NOW	6.2	Cheapest fwdPe here (7.85), PEG 0.26, all TFs positive with pos_in_range 2-37% — small-cap sleeper.
10	CALX	BUY NOW	6.1	Big +50/+40 mid/long daily forecasts, pos_in_range 0-2% (no chase), positive AI broadband contract news.
11	ONON	BUY PULLBACK	5.9	Clean fundamentals and moderate forecasts but weekly forecast mostly flat/negative — no urgency.
12	MLCO	WAIT	5.7	Nice weekly +33/+42 mid/long forecasts and cheap fwdPe 8.37, but pos_in_range 92-98% on 4h/1d.
13	KKR	WAIT	5.5	Record Q2 beat is priced in — near-term forecasts flat to slightly negative and pos_in_range 72-81%.
14	GAU	WAIT	5.3	Enormous 1h/4h forecasts (+33 to +52) but weekly forecast turning deeply negative (-13 to -26).
15	EQX	WAIT	5.1	Big short-TF forecasts and gold M&A catalyst, but weekly forecast is -32/-37 mid/long — trend broken.
16	AGI	WAIT	5.0	Great fundamentals (PEG 0.23, margins 52%) but weekly forecast -36/-45 mid/long and pos_in_range 0 across the board — falling knife.
17	HNRG	WAIT	4.9	Coal tailwinds and DOE funding, but data cuts off mid-stream and setup is stale.
18	SE	WAIT	4.8	Weekly recent +24.88% already ran — short/mid forecasts turning negative on 1h/4h.
19	SRAD	WAIT	4.7	Analyst price target cuts (Guggenheim, Stifel) offset the +27-30% mid/long forecasts.
20	QTWO	WAIT	4.6	bullish_prob only 0.40 and 1h forecast -23% short/-14 mid — extended at pos_in_range 82-100%.
21	CELH	WAIT	4.5	Analysts modeling earnings DECLINE into Aug 6 print — event risk trumps the +50 mid/long daily forecast.
22	PGY	WAIT	4.4	Record Q2 delivered but data cuts off; shortFloat 18.8% and D/E 1.81 add risk.
23	DCBO	WAIT	4.2	Substantial issuer bid is neutral-positive but short/mid forecasts negative on 1h/4h and daily.
24	STEP	WAIT	4.0	ROE -750, operating margin -45.64, PE null — fundamentals don't hold up despite screen match.
25	NOW	AVOID	3.9	Up to 1,000 layoffs headline plus 1h/4h forecasts -12/-6 and near_term_bullish 0 — thesis cracking.
26	APP	AVOID	3.7	Weekly forecast -14/-45/-60 is catastrophic despite intraday bounce — pre-earnings landmine.
27	HSAI-dup	WAIT	0.0	placeholder — remove
28	FRSH	AVOID	3.4	All four TFs have NEGATIVE forecasts (-3 to -22), bullish_prob 0, target upside only 13.4%.
29	ITRG	AVOID	3.0	Zacks Strong Sell July 30 and weekly forecast -31/-34 mid/long — screen match is a trap.
30	PFSI	AVOID	2.9	Piper Sandler downgrade July 31 and stock actively falling — don't catch it here.
31	FICO	AVOID	2.4	Worst single-day drop in 6 years on downside guidance July 30 — GARP thesis is broken.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord